Oxford BioMedica PLC (OXB) — Tangible Net Worth Ratio

Latest as of June 2025: 25.7%

Oxford BioMedica PLC (OXB) has a Tangible Net Worth Ratio of 25.7% as of June 2025. This metric is calculated by deducting intangible assets (GBX24.32 Million) from net assets (GBX32.73 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See OXB current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

25.7%
Tangible equity / total equity

Net Assets (Equity)

GBX32.73 Million
GBX

Intangible Assets

GBX24.32 Million
Goodwill, patents, brand value

Total Assets

GBX216.32 Million
GBX

Oxford BioMedica PLC Tangible Net Worth Ratio (1996–2024)

This chart shows how Oxford BioMedica PLC's Tangible Net Worth Ratio has changed across 30 annual periods from 1996 to 2024. As of June 2025, the ratio stands at 25.7%, reflecting net assets of GBX32.73 Million with intangible assets of GBX24.32 Million GBX. See defensive interval ratio of Oxford BioMedica PLC to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Oxford BioMedica PLC (1996–2024)

The table below presents the year-by-year Tangible Net Worth Ratio for Oxford BioMedica PLC from 1996 to 2024, covering 30 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Oxford BioMedica PLC.

Year Tangible NW Ratio Net Assets (GBX) Intangible Assets Total Assets Change (pp)
2024 51.7% GBX60.49 Million GBX29.22 Million GBX231.64 Million ▼ -8.5 pp
2023 60.2% GBX77.83 Million GBX30.98 Million GBX252.34 Million ▲ +4.7 pp
2022 55.4% GBX236.19 Million GBX105.22 Million GBX460.18 Million ▼ -44.5 pp
2021 100.0% GBX187.34 Million GBX52.00K GBX237.23 Million ▲ +0.0 pp
2020 99.9% GBX112.75 Million GBX73.00K GBX183.93 Million ▲ +0.1 pp
2019 99.9% GBX75.63 Million GBX95.00K GBX122.93 Million ▲ +0.2 pp
2018 99.7% GBX34.74 Million GBX117.00K GBX112.40 Million ▲ +1.2 pp
2017 98.4% GBX6.15 Million GBX97.00K GBX65.40 Million ▲ +9.0 pp
2016 89.5% GBX12.62 Million GBX1.33 Million GBX56.94 Million ▲ +5.5 pp
2015 84.0% GBX10.89 Million GBX1.74 Million GBX51.85 Million ▼ -6.9 pp
2014 90.9% GBX23.04 Million GBX2.11 Million GBX33.80 Million ▲ +20.4 pp
2013 70.4% GBX8.90 Million GBX2.63 Million GBX13.64 Million ▼ -14.7 pp
2012 85.1% GBX19.64 Million GBX2.93 Million GBX24.42 Million ▲ +2.6 pp
2011 82.5% GBX17.77 Million GBX3.11 Million GBX26.09 Million ▲ +40.1 pp
2010 42.4% GBX11.61 Million GBX6.68 Million GBX25.64 Million ▼ -4.6 pp
2009 47.0% GBX20.98 Million GBX11.12 Million GBX43.95 Million ▼ -5.2 pp
2008 52.2% GBX23.27 Million GBX11.12 Million GBX43.12 Million ▼ -1.1 pp
2007 53.3% GBX31.93 Million GBX14.91 Million GBX61.16 Million ▼ -41.2 pp
2006 94.5% GBX30.09 Million GBX1.67 Million GBX35.54 Million ▼ -2.0 pp
2005 96.5% GBX46.60 Million GBX1.64 Million GBX49.24 Million ▲ +2.6 pp
2004 93.8% GBX26.38 Million GBX1.63 Million GBX28.58 Million ▼ -5.8 pp
2003 99.6% GBX35.21 Million GBX135.00K GBX36.71 Million ▲ +0.3 pp
2002 99.3% GBX25.53 Million GBX185.00K GBX26.79 Million ▼ -0.1 pp
2001 99.4% GBX37.51 Million GBX234.00K GBX39.26 Million ▲ +1.6 pp
2000 97.8% GBX12.98 Million GBX283.00K GBX14.32 Million ▲ +6.6 pp
1999 91.3% GBX3.80 Million GBX332.00K GBX4.60 Million ▼ -0.7 pp
1998 92.0% GBX4.76 Million GBX381.00K GBX5.24 Million ▲ +7.6 pp
1997 84.4% GBX2.76 Million GBX431.00K GBX3.20 Million ▲ +28.1 pp
1996 56.3% GBX1.12 Million GBX492.00K GBX1.25 Million ▲ +0.0 pp
1996 56.3% GBX1.12 Million GBX492.00K GBX1.25 Million
pp = percentage points